EyePoint, Inc. (EYPT)
Last updated: 2026-10-20 23:17:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
EyePoint, Inc. (EYPT) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $0.41, with a market capitalization of $257.77M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.40 to $19.11. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$257.77M | |
$0.42 | |
$39.40 | |
$0.40 | |
$0.44 | |
48.85M | |
7.02M | |
-- | |
$19.11 | |
$0.40 | |
-- | |
-- |
EyePoint, Inc. (EYPT) After-Hours Stock Price
EyePoint, Inc. (EYPT) is trading at $0.41 in after-hours trading as of 2026-10-20 23:14:00, down 6.14% ($0.03) from the regular-session close of $0.44.
After-hours trading shows how investors are pricing EYPT after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
EyePoint, Inc. (EYPT) 7-Day Stock Price Change
Over the past seven days, EyePoint, Inc. (EYPT) moved from $3.40 to $0.41, representing a decline of 88.06% ($2.99).
The stock traded between $0.40 and $3.57 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 28.50 million shares, up versus the previous seven-day period, indicating higher trading activity.
EYPT 52-Week Price Position
Position in Range: 0.0%
EYPT is currently trading at $0.41, placing it 0.0% of the way from its 52-week low of $0.40 to its 52-week high of $19.11. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is EyePoint, Inc. (EYPT)?
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
EyePoint, Inc. Information
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 214 |
| Exchange | NASDAQ |
| Company Website |
How to Buy EyePoint, Inc. (EYPT) Stock on MEXC
Eligible investors can buy real shares of EyePoint, Inc. (EYPT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is EyePoint, Inc. (EYPT) stock price today?
2.Is EYPT stock going up or down today?
3.What is EYPT pre-market price?
4.What is EYPT after-hours price?
5.Is EYPT stock trading now?
6.Where does EYPT sit relative to its 52-week high and low?
7.What sector is EyePoint, Inc. in?
8.What is EyePoint, Inc.'s market capitalization and where is it listed?
9.How is EYPT valued in terms of P/E ratio and EPS?
10.Does EyePoint, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
EYPT Stock Calculator
Estimate the value between EYPT shares and USD.
EYPT Shares to USD
1.00 EYPT shares = 0.406 USD
Calculations are estimates based on the latest available price and are for reference only.


